Literature DB >> 12689698

Characterization of two Turkish beta-hexosaminidase mutations causing Tay-Sachs disease.

Hatice Asuman Ozkara1, Konrad Sandhoff.   

Abstract

Two homoallelic mutations have recently been identified in the alpha-subunit of hexosaminidase A (EC 3.2.1.52) causing the infantile form of Tay-Sachs disease in Turkish patients. Both of these mutations, a 12 bp deletion (1096-1107 or 1098-1108 or 1099-1109) in exon 10 and a point mutation (G1362 to A, Gly454 to Asp) in exon 12, are located in the catalytic domain of the hexosaminidase alpha-chain. In order to determine whether these mutations affect the function of the catalytic domain or result in an instable protein, both mutant cDNAs were overexpressed in COS-1 cells. As judged by Western blotting, transfections of wild-type cDNA produced pro-alpha-chain and mature alpha-chain in parallel with a fivefold increase in cellular hexosaminidase activity using the synthetic substrate 4-methylumbelliferyl beta-N-acetylglucosamine 6-sulfate (MUGS). However, both mutants produced only pro-alpha-chains, although no mature form or detectable hexosaminidase activity towards two different synthetic substrates was observed. These data are consistent with the biochemical phenotype of infantile Tay-Sachs disease. We conclude that the overexpressed mutant pro-alpha-chains were misfolded and could not undergo further proteolytic processing to the active form of the enzyme in the lysosome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689698     DOI: 10.1016/s0387-7604(02)00213-9

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

1.  Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.

Authors:  Incilay Sinici; Maryam Zarghooni; Michael B Tropak; Don J Mahuran; H Asuman Ozkara
Journal:  Biochem Genet       Date:  2006-04-28       Impact factor: 1.890

2.  Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu→Lys, p.318Trp→Cys) arylsulfatase A mutations.

Authors:  Adem Özkan; Hatice Asuman Özkara
Journal:  Intractable Rare Dis Res       Date:  2016-11

3.  Assessing the severity of the small inframe deletion mutation in the alpha-subunit of beta-hexosaminidase A found in the Turkish population by reproducing it in the more stable beta-subunit.

Authors:  I Sinici; M B Tropak; D J Mahuran; H A Ozkara
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Does serum hexosaminidase activity play a role in the diagnosis of strangulated bowel obstruction? An experimental study.

Authors:  M Tahir Oruç; M Mahir Ozmen; Orhan Kazan; Arife Polat Düzgün; H Asuman Ozkara; Deniz Arik; Selda Seçkin; Faruk Coşkun
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

5.  Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.

Authors:  Mazal Karpati; Ephraim Gazit; Boleslaw Goldman; Amos Frisch; Roberto Colombo; Leah Peleg
Journal:  Neurogenetics       Date:  2003-11-27       Impact factor: 2.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.